Global Aminoglycosides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Aminoglycosides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar); the term can also refer more generally to any organic molecule that contains aminosugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria.
Aminoglycosides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aminoglycosides market is projected to reach US$ 1183.4 million in 2034, increasing from US$ 1050.2 million in 2022, with the CAGR of 1.7% during the period of 2024 to 2034. Demand from Skin Infection and Respiratory Diseases are the major drivers for the industry.
Asia Pacific accounted for the largest share of revenue in 2014 that is due to higher incidence rate of multi-drug resistant tuberculosis that needs second line drugs for treatment is attributive towards a larger considerably larger share of kanamycin and capreomycin in the Asia Pacific region along with the significant availability of other aminoglycosides as well.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aminoglycosides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Kremoint Pharma Pvt.
Vega Pharma
Jiangxi Bolai Pharmacy,
Xian Wison Biological Technology,
Hangzhou Uniwise International,
HuvePharma
Yi Chang Veterinary Medicine Factory
Medson Pharmaceuticals
Medico Remedies
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Others
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Aminoglycosides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aminoglycosides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aminoglycosides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aminoglycosides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aminoglycosides introduction, etc. Aminoglycosides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Aminoglycosides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Aminoglycosides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aminoglycosides market is projected to reach US$ 1183.4 million in 2034, increasing from US$ 1050.2 million in 2022, with the CAGR of 1.7% during the period of 2024 to 2034. Demand from Skin Infection and Respiratory Diseases are the major drivers for the industry.
Asia Pacific accounted for the largest share of revenue in 2014 that is due to higher incidence rate of multi-drug resistant tuberculosis that needs second line drugs for treatment is attributive towards a larger considerably larger share of kanamycin and capreomycin in the Asia Pacific region along with the significant availability of other aminoglycosides as well.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aminoglycosides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Kremoint Pharma Pvt.
Vega Pharma
Jiangxi Bolai Pharmacy,
Xian Wison Biological Technology,
Hangzhou Uniwise International,
HuvePharma
Yi Chang Veterinary Medicine Factory
Medson Pharmaceuticals
Medico Remedies
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Others
Segment by Application
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Aminoglycosides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aminoglycosides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aminoglycosides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aminoglycosides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aminoglycosides introduction, etc. Aminoglycosides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Aminoglycosides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices